Summer Sale
50% off Premium Yearly
NASDAQ:CXRX
Concordia Healthcare Corp (CXRX)
Financials 
Technical Analysis This has grown by acquisition, buying a lot of drugs. They sell drugs to over 100 companies. Generates EBITDA of around $600 million. Have $3.5 billion of debt. They free cash flow $300 million a year which they can pay down the debt with. Thinks there is a very good chance this company will not be public in a couple of weeks. Dividend yield of 1.14%.
John O'Connell, CFA- «
- ‹
- 1
- ›
- »
Concordia Healthcare Corp (CXRX) Frequently Asked Questions
What is Concordia Healthcare Corp stock symbol?
Concordia Healthcare Corp is a American stock, trading under the symbol CXRX (previously CXRX-Q on Stockchase) on the NASDAQ (CXRX). It is usually referred to as NASDAQ:CXRX or CXRX
Is Concordia Healthcare Corp a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on CXRX (previously CXRX-Q on Stockchase) on Stockchase. Read the latest expert commentary for Concordia Healthcare Corp.
Is Concordia Healthcare Corp a good investment or a top pick?
Concordia Healthcare Corp was recommended as a Top Pick by John O'Connell, CFA on 2016-05-03. Read the latest stock experts ratings for Concordia Healthcare Corp.
Why is Concordia Healthcare Corp stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Concordia Healthcare Corp.
Is Concordia Healthcare Corp worth watching?
Concordia Healthcare Corp is covered by Stockchase experts and is worth watching.
What is Concordia Healthcare Corp stock price?
On 2019-08-07, Concordia Healthcare Corp (CXRX) stock closed at a price of $0.19.
(A Top Pick May 3/16. Down 95%.) This was a mistake. There are shareholder lawsuits involved. It was growth by acquisition, and it looks like they dramatically overpaid for some assets. They got involved with generic competition, and as well, the perfect storm of politics of the last election really killed the stock.